Second-line chemotherapy after disease progression following first-line FOLFOXIRI in advanced pancreatic cancer patients

被引：0
|
作者：
Vasile, E. [1 ]
Vivaldi, C. [1 ]
Fornaro, L. [1 ]
Caparello, C. [1 ]
Musettini, G. [1 ]
Pasquini, G. [1 ]
Catanese, S. [1 ]
Lencioni, M. [1 ]
Ricci, S. [1 ]
Falcone, A. [1 ]
机构：
[1] AOU Pisana, Pisa, Italy
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
L26
引用
收藏
页码：98 / 98
页数：1
相关论文
共 50 条
  • [1] Second-line treatment after disease progression following first-line chemotherapy with modified FOLFIRINOX in advanced pancreatic cancer patients
    Vivaldi, C.
    Vasile, E.
    Fornaro, L.
    Caparello, C.
    Musettini, G.
    Pasquini, G.
    Lencioni, M.
    Ricci, S.
    Falcone, A.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S456 - S457
  • [2] Outcome of Second-Line Treatment After First-Line Chemotherapy With the GONO FOLFOXIRI Regimen
    Fornaro, Lorenzo
    Vasile, Enrico
    Masi, Gianluca
    Loupakis, Fotios
    Baldi, Giacomo Giulio
    Allegrini, Giacomo
    Salvatore, Lisa
    Cremolini, Chiara
    Cupini, Samanta
    Cortesi, Enrico
    Tuzi, Alessandro
    Granetto, Cristina
    Brunetti, Isa Maura
    Ricci, Sergio
    Falcone, Alfredo
    CLINICAL COLORECTAL CANCER, 2012, 11 (01) : 71 - 76
  • [3] Second-line treatments in patients with metastatic colorectal cancer progressed after first-line FOLFOXIRI
    Masi, G.
    Vasile, E.
    Loupakis, F.
    Fornaro, L.
    Salvatore, L.
    Cupini, S.
    Stasi, I.
    Brunetti, I. M.
    Andreuccetti, M.
    Falcone, A.
    EJC SUPPLEMENTS, 2009, 7 (02): : 346 - 347
  • [4] SECOND-LINE TREATMENTS IN PATIENTS WITH METASTATIC COLORECTAL CANCER PROGRESSED AFTER FIRST-LINE FOLFOXIRI
    Fornaro, Lorenzo
    Vasile, Enrico
    Masi, Gianluca
    Loupakis, Fotios
    Salvatore, Lisa
    Stasi, Irene
    Baldi, Giacomo Giulio
    Cupini, Samanta
    Barbara, Cecilia
    Pfanner, Elisabetta
    Brunetti, Isa Maura
    Di Donato, Samantha
    Caponi, Sara
    Allegrini, Giacomo
    Antonuzzo, Andrea
    Ricci, Sergio
    Chiara, Silvana
    Vitello, Stefano
    Andreuccetti, Michele
    Falcone, Alfredo
    ANNALS OF ONCOLOGY, 2009, 20
  • [5] Second-line chemotherapy after early disease progression during first-line chemotherapy containing bevacizumab for patients with metastatic colorectal cancer
    Shun Yamamoto
    Kengo Nagashima
    Takeshi Kawakami
    Seiichiro Mitani
    Masato Komoda
    Yasushi Tsuji
    Naoki Izawa
    Kentaro Kawakami
    Yoshiyuki Yamamoto
    Akitaka Makiyama
    Kentaro Yamazaki
    Toshiki Masuishi
    Taito Esaki
    Takako Eguchi Nakajima
    Hiroyuki Okuda
    Toshikazu Moriwaki
    Narikazu Boku
    BMC Cancer, 21
  • [6] Second-line chemotherapy after early disease progression during first-line chemotherapy containing bevacizumab for patients with metastatic colorectal cancer
    Yamamoto, Shun
    Nagashima, Kengo
    Kawakami, Takeshi
    Mitani, Seiichiro
    Komoda, Masato
    Tsuji, Yasushi
    Izawa, Naoki
    Kawakami, Kentaro
    Yamamoto, Yoshiyuki
    Makiyama, Akitaka
    Yamazaki, Kentaro
    Masuishi, Toshiki
    Esaki, Taito
    Nakajima, Takako Eguchi
    Okuda, Hiroyuki
    Moriwaki, Toshikazu
    Boku, Narikazu
    BMC CANCER, 2021, 21 (01)
  • [7] Progression-free survival in first-line chemotherapy is a prognostic factor in second-line chemotherapy in patients with advanced gastric cancer
    Kenji Hashimoto
    Atsuo Takashima
    Kengo Nagashima
    Shun-suke Okazaki
    Takako Eguchi Nakajima
    Ken Kato
    Tetsuya Hamaguchi
    Yasuhide Yamada
    Yasuhiro Shimada
    Journal of Cancer Research and Clinical Oncology, 2010, 136 : 1059 - 1064
  • [8] Progression-free survival in first-line chemotherapy is a prognostic factor in second-line chemotherapy in patients with advanced gastric cancer
    Hashimoto, Kenji
    Takashima, Atsuo
    Nagashima, Kengo
    Okazaki, Shun-suke
    Nakajima, Takako Eguchi
    Kato, Ken
    Hamaguchi, Tetsuya
    Yamada, Yasuhide
    Shimada, Yasuhiro
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2010, 136 (07) : 1059 - 1064
  • [9] Efficacy of second-line chemotherapy after a first-line triplet in patients with metastatic colorectal cancer
    Bazarbashi, S.
    Hakoun, A. M.
    Gad, A. M.
    Elshenawy, M. A.
    Aljubran, A.
    Alzahrani, A. M.
    Eldali, A.
    CURRENT ONCOLOGY, 2019, 26 (01) : E24 - E29
  • [10] Taxol as second-line treatment in patients with advanced ovarian cancer after platinum-based first-line chemotherapy
    Mayerhofer, K
    Kucera, E
    Zeisler, H
    Speiser, P
    Reinthaller, A
    Sevelda, P
    GYNECOLOGIC ONCOLOGY, 1997, 64 (01) : 109 - 113
12345